Olysio cleared in Europe

|By:, SA News Editor

The European Commission approves J&J (JNJ) unit Janssen Pharmaceuticals' Olysio (simeprivir) for the treatment of Hepatitis C genotype 1 and 4 infection in combination with other medicines.

Olysio is already approved for sale in the U.S., Japan, Canada and Russia. It will be available in the EU in 2H 2014.

Related tickers: (GILD) (ABBV) (BMY) (MRK)